S-23: The Sarms King
S-23 is a selective androgen receptor modulator (SARM) developed by the pharmaceutical company GTX Inc. S-23 binds to the androgen receptor more effectively than older molecules, such as andarin, and in animal studies, has shown an excellent relationship between anabolic and androgenic effects. S-23 can bring a dose-dependent suppression of spermatogenesis, with spontaneous recovery after […]
